or Try an Advanced Search...

    ETF Components for FBT - First Trust Amex Biotech Index Fund


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NTRA A -2.97 5.20
    ITCI A -0.11 4.22
    BRKR D -0.74 4.13
    HALO D 0.85 3.91
    UTHR A -0.03 3.71
    MTD B 0.01 3.64
    WAT D 1.09 3.57
    NBIX C -1.32 3.53
    CORT F 1.15 3.53
    EXEL A -0.56 3.52
    ARGX F 0.26 3.48
    MRNA A -1.20 3.43
    BMRN A -1.33 3.41
    REGN C 0.06 3.36
    EXAS B -4.33 3.33
    RGEN D 0.05 3.32
    GMAB D 1.02 3.26
    PTCT F 0.73 3.24
    INSM D -3.95 3.22
    VRTX C -0.02 3.19
    AMGN D 1.74 3.04
    ILMN F 0.39 2.99
    INCY F -1.04 2.97
    ALKS F -0.55 2.95
    DVAX D 2.51 2.89
    BIIB F 0.95 2.76
    GILD F 0.39 2.73
    BGNE F -1.64 2.68
    ALNY F -0.78 2.66
    ACAD F -1.29 2.08

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology S&P 500 Medicine Cancer Nasdaq 100 Life Sciences Inflammation Monoclonal Antibodies Monoclonal Antibody Biology Chemical Compounds Cystic Fibrosis Diabetes Disorders Genzyme Infectious Diseases Lymphoma Pain Schizophrenia
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Long-Term Care Facilities

    Recent News for First Trust Amex Biotech Index Fund & its Holdings

    Date Stock Title
    Apr 19 REGN Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
    Apr 19 BIIB What's in Store for Biogen (BIIB) This Earnings Season?
    Apr 19 BIIB Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics
    Apr 19 ILMN These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
    Apr 19 GILD FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk
    Apr 19 VRTX Is Vertex Pharmaceuticals Stock a Millionaire Maker?
    Apr 19 MRNA FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet
    Apr 18 GILD US FDA mandates label updates on CAR-T cancer therapies
    Apr 18 GILD Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
    Apr 18 REGN Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
    Apr 18 GILD Gilead Sciences Publishes 2023 ESG Impact Report
    Apr 18 ILMN Engineering a Cool Career in Biotech - and Volunteering Along the Way
    Apr 18 HALO Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
    Apr 18 HALO Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
    Apr 18 BMRN Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
    Apr 18 GILD Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
    Apr 18 BIIB Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
    Apr 18 VRTX Vertex starts rolling FDA submission for non-opioid pain therapy
    Apr 18 VRTX Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
    Apr 18 ALNY Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
    The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund Stock Market Index Biotechnology
    Back to the Main FBT Page...